EMH.V · Emerald Health Therapeutics, Inc

-

Please sign in to comment on EMH.V

1 Comment

Admin

4 years ago

Emerald Health Therapeutics, Inc is currently in a long term downtrend where the price is trading 0.3% below its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.

Emerald Health Therapeutics, Inc's total revenue sank by 63.7% to $3M since the same quarter in the previous year.

Its net income has increased by 33.4% to $-11M since the same quarter in the previous year.

Finally, its free cash flow grew by 96.2% to $-541K since the same quarter in the previous year.

Based on the above factors, Emerald Health Therapeutics, Inc gets an overall score of 3/5.

Exchange	V
CurrencyCode	CAD
ISIN	CA29102R1064
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Dividend Yield	0.0%
Beta	1.07
Market Cap	51M
PE Ratio	None
Target Price	0.4

ABOUT

Emerald Health Therapeutics, Inc

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

EMH.V · Emerald Health Therapeutics, Inc

-

Emerald Health Therapeutics, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Emerald Health Therapeutics, Inc using a moving average strategy